In the United States, Provigil is the only FDA-approved brand-name version of modafinil, and several FDA-approved generics are available through licensed pharmacies with a valid prescription. Indian-manufactured generics such as Modalert and Modvigil are frequently discussed online, but they are not FDA-approved and are not legally sold through US pharmacies. For most Americans, the highest-rated options are those dispensed legally through regulated pharmacies under medical supervision.
The Only FDA-Approved Brand: Provigil
Provigil, originally developed by Cephalon and now owned by Teva Pharmaceuticals, is the brand-name version of modafinil approved by the US Food and Drug Administration. It is indicated for narcolepsy, obstructive sleep apnea, and shift work sleep disorder in adults. It is available in 100 mg and 200 mg oral tablets.
Provigil is dispensed through licensed US pharmacies with a valid prescription. As a Schedule IV controlled substance under federal law, modafinil cannot be obtained legally without a prescription. Brand-name Provigil typically carries a significant price premium compared to generic versions.
For patients seeking the original FDA-reviewed formulation, Provigil is the only brand-name option legally available in the United States.
FDA-Approved Generic Modafinil in US Pharmacies
Most prescriptions in the US are filled with generic modafinil rather than brand-name Provigil. Licensed pharmacies stock generics manufactured by companies such as Teva, Alembic, BionPharma, and Apotex.
All FDA-approved generics must demonstrate bioequivalence to Provigil. Federal standards require that a generic product’s pharmacokinetic parameters fall within an accepted range relative to the brand-name drug. This ensures comparable absorption and systemic exposure under regulated conditions.
There are no large head-to-head clinical trials showing meaningful differences in effectiveness or safety among FDA-approved generic manufacturers. In practice, the specific manufacturer a patient receives is usually determined by pharmacy supply contracts and insurance formularies.
For patients filling prescriptions through US pharmacies, these FDA-approved generics represent the standard and legally accessible forms of modafinil.
Indian Generic Brands Commonly Discussed Online
A separate market exists for Indian-manufactured generic modafinil brands sold by overseas online pharmacies. These products are not FDA-approved for sale in the United States and are not dispensed through licensed US pharmacies.
Two of the most frequently cited brands are:
Modalert 200 mg, manufactured by Sun Pharmaceuticals, one of India’s largest pharmaceutical companies. Modalert has long been considered a flagship Indian generic in online discussions. Recent reports indicate that Sun Pharma has restricted certain international export channels, which has affected availability outside India.
Modvigil 200 mg, manufactured by HAB Pharmaceuticals. It is often positioned as a lower-cost alternative to Modalert and is widely distributed through online vendors.
Other brands include:
Modafil MD, produced by Intas Pharma. It is formulated as an orally disintegrating tablet and marketed for sublingual use. While vendors often claim faster onset compared to standard tablets, these products have not undergone FDA review for US marketing, and there are no FDA-reviewed head-to-head trials demonstrating clinically meaningful differences in onset or duration relative to approved oral tablets.
Modafresh, produced by Sunrise Remedies, a privately held manufacturer. As with other Indian generics sold online, it is not FDA-approved for US distribution.
These products are widely referenced in online nootropic communities. However, none of the Indian brands listed above are approved by the FDA for sale in the United States, and they are not available through licensed American pharmacies.
Legal Status in the United States
Modafinil is classified as a Schedule IV controlled substance under US federal law. A valid prescription from a licensed US healthcare provider is required to possess it legally.
Indian-manufactured brands sold online are not approved for US sale. Importation of controlled substances without proper authorization may result in seizure by US Customs and can carry legal consequences. Only modafinil dispensed through licensed US pharmacies pursuant to a valid prescription is clearly lawful.
Federal regulations limit Schedule IV prescriptions to a maximum of five refills within six months before a new prescription is required.
For individuals seeking modafinil legally in the United States, the appropriate path is consultation with a licensed healthcare provider and fulfillment through a regulated pharmacy.
Safety and Side Effects Across Brands
The safety profile of modafinil does not differ by brand when the active ingredient is the same. Common side effects include headache, nausea, anxiety, and insomnia.
Serious but rare adverse reactions include severe dermatologic conditions such as Stevens-Johnson syndrome. FDA prescribing information includes warnings regarding serious rash, psychiatric symptoms, hypersensitivity reactions, and potential cardiovascular effects. Modafinil is not approved for use in pediatric patients and carries warnings regarding use during pregnancy.
Patients should review the full prescribing information and discuss risks with a qualified healthcare provider before use.
What “Top-Rated” Means in Practice
Within the regulated US healthcare system, there is one brand-name product and several FDA-approved generics that must meet federal bioequivalence standards. “Top-rated” in this setting generally reflects insurance coverage, pharmacy availability, and cost rather than demonstrated clinical superiority.
Outside the US pharmacy system, certain Indian generics are frequently referenced online. However, they are not FDA-approved for US sale and operate outside standard regulatory oversight.
For most US patients, the highest-rated option in practical terms is an FDA-approved product dispensed legally through a licensed pharmacy under medical supervision.
Sources
- U.S. Food and Drug Administration. (2015). PROVIGIL® (modafinil) tablets, for oral use, C-IV: Prescribing information. U.S. Department of Health and Human Services. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf
- Greenblatt, K., & Adams, N. (2023, February 6). Modafinil. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK531476/
- U.S. Drug Enforcement Administration. (n.d.). Drug scheduling. https://www.dea.gov/drug-information/drug-scheduling
- Drugs.com. (n.d.). Is Provigil a controlled substance? https://www.drugs.com/medical-answers/provigil-controlled-substance-3564088/